You are here: Industry Insights > Abbott

News List

Abbott Receives FDA 510(k) Clearance for Rapid Handheld Blood Test for Concussions americanpharmaceuticalreview
January 15, 2021
Abbott has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions.
Abbott receives CE mark for COVID-19 IgG quantitative antibody blood test europeanpharmaceuticalreview
December 17, 2020
The new quantitative SARS-CoV-2 IgG lab-based serology test developed by Abbott has been given the CE mark.
Abbott launches Duphalac Bears in India expresspharma
October 29, 2020
Abbott has launched Duphalac Bears, a new product featuring fruit-flavoured gummy bears designed to support children’s digestive health, helping them live healthier lives.
Abbott Receives EUA for COVID-19 IgM Antibody Blood Test americanpharmaceuticalreview
October 16, 2020
Abbott announced the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test for use on the ARCHITECT® and Alinity™ platforms.
Abbott Releases ID NOW COVID-19 Interim Clinical Study Results americanpharmaceuticalreview
October 14, 2020
In a continuing effort to provide the facts about ID NOW to support public health interests, Abbott is sharing new interim clinical data results on its ID NOW COVID-19 rapid test.
Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold americanpharmaceuticalreview
September 07, 2020
Abbott has announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company's new Esprit™ BTK Everolimus Eluting Resorbable Scaffold System.
Abbott gets DCGI approval for Ivabradine expresspharma
September 03, 2020
Abbott has received approval from the Drugs Controller General of India (DCGI) for its Ivabradine, once-a-day formulation.
Abbott's fast, $5, 15-minute, easy-to-use COVID-19 antigen test receives FDA Emergency Use Authorization worldpharmanews
August 31, 2020
Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection.
Abbott Evaluates New Device to Treat Recurrent Atrial Fibrillation americanpharmaceuticalreview
August 07, 2020
Abbott announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation (PAF), a type of irregular heartbeat.
FDA approves new heart rhythm devices featuring Bluetooth connectivity and continuous remote monitoring europeanpharmaceuticalreview
July 08, 2020
Abbott’s Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices are given approval.

Previous page 1 2 3 4 5 6 7 Next page